zhjmedical.com - ZJYL Total Enterprise Value

Graphic logo of zhjmedical.com (ZJYL)

Jin Medical International is expanding its global export of rehabilitation equipment, aiming to increase its presence in the specialized aids niche through B2B channels. The brand is valued for the ergonomics and technological sophistication of its wheelchairs, which restore mobility to users. This chart illustrates that the asset's market value is 362.06. Current growth is driven by demand in Japan and China, while future potential is linked to the launch of automated factories.

ZJYL (zhjmedical.com) Total Company Value history from 11/23/2025 to 10/31/2026
Finished products of zhjmedical.com

Global sales of rehabilitation equipment from Jin Medical International (ZJYL) require an accurate accounting of enterprise value. This metric aggregates market capitalization and debt obligations, subtracting cash to determine the actual buyout price of the asset. Such logic allows market noise to be stripped away from fundamental changes. Analyzing the capital structure helps avoid overpaying for an overvalued business. The valuation dynamics of Jin Medical International (ZJYL) based on the EV metric confirm the stability of the investment trajectory.

Who Jin Medical International competes with

Aggregate Business Value BSX (Boston Scientific Corp)|EW: Real Price to Acquire Entire Company|Total Enterprise Value ResMed Corporation|Insulet Corporation (PODD) - Total Company Value|ZBH (Zimmer Biomet Holdings) - Total Company Value|Total Company Value CooperCompanies|Invisalign (ALGN) - Company Buyout Price|Total Company Value Globus Medical Corp (GMED)|TMDX: Full Business Value|Enterprise Value ATEC (Alphatec Holdings, Inc.)|artivion.com (AORT) - Total Enterprise Value|Enovis - Enterprise Value|Integra LifeSciences Corp (IART) - Real Price to Acquire Entire Company|ESTA: Enterprise Value|BBNX - Company Buyout Price|IRMD (IRADIMED CORPORATION) - Enterprise Value|Enterprise Value embecta.com|Total Company Value Tandem Diabetes Care, Inc. (TNDM)|Total Company Value AXGN (AxoGen Inc)|Enterprise Value SIBN (SI-BONE Corp)|Company Buyout Price Orthofix Corp (OFIX)|BVS: Real Price to Acquire Entire Company|Full Business Value KIDS|TMCI: Enterprise Value|Total Enterprise Value Blade Air Mobility (SRTA)|CARL (Carlsmed Corp) - Enterprise Value|Business Value RXST (RxSight Ophthalmic)|Real Price to Acquire Entire Company CLPT (ClearPoint Neuro, Inc.)|STXS (stereotaxis.com) - Value Adjusted for Debt and Cash|Total Company Value Neuronetics STIM|SGHT - Real Price to Acquire Entire Company|Orchestra BioMed, Inc. - Enterprise Value|Total Enterprise Value Anika Therapeutics|NSPR: Enterprise Value|Business Value VANI|XTNT (Xtant Medical Holdings, Inc.) - Enterprise Value|NeuroOne (NMTC) - Company Buyout Price|Enterprise Value MODD|Real Price to Acquire Entire Company Myomo Inc MYO|Enterprise Value COCH (Envoy Medical, Inc.)|Enterprise Value vivoslife.com VVOS|NVNO - Total Company Value|SINT: Total Company Value|TNON (Tenon Medical, Inc) - Real Price to Acquire Entire Company|Lifeward Ltd. - Value Adjusted for Debt and Cash|AMIX (Autonomix Medical Inc.) - Enterprise Value|Total Enterprise Value invobioscience.com IVF|Total Company Value Bone Biologics Corp (BBLG)|Axonics Inc. (AXNX) - Full Takeover Company Value|Biolase, Inc. - Real Price to Acquire Entire Company|Enterprise Value Dynatronics Corp DYNT|Paragon 28 Corp - Enterprise Value|Company Buyout Price INVO Bioscience, Inc. INVO